Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
15,085 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00075933 | ARQ 501 in Subjects With Cancer | completed | Phase 1 | 80 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00099190 | ARQ 501 in Combination With Docetaxel in Patients With Cancer | completed | Phase 1 | 50 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) |
| 1 |
| Apr 28, 2009 |
| clinicaltrials |
| NCT00127829 | Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic(AGUS) | completed | Phase 1 | 66 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00547261 | Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer | terminated | Phase 1 | 6 | SanofiINDUSTRY | 1 | Apr 17, 2009 | clinicaltrials |
| NCT00881244 | Study of AS1411 in Advanced Solid Tumours | completed | Phase 1 | 30 | Antisoma ResearchINDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00185861 | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | completed | Phase 1 | 12 | Stanford UniversityOTHER | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00499967 | Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts | completed | Phase 1 | 202 | Gilead SciencesINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00070083 | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | completed | Phase 1 | — | British Columbia Cancer AgencyOTHER | 2 | Apr 7, 2009 | clinicaltrials |
| NCT00045136 | Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | completed | Phase 1 / Phase 2 | — | Poniard PharmaceuticalsINDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00080054 | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | completed | Phase 1 | 24 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00102505 | A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 36 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00120939 | Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | completed | Phase 1 | 25 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00040573 | Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. | completed | Phase 1 / Phase 2 | 18 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00695851 | Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | completed | Phase 1 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00064584 | Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) | completed | Phase 1 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 24, 2009 | clinicaltrials |
| NCT00452257 | A Study of Enzastaurin in Patients With Leukemia | completed | Phase 1 | 18 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 19, 2009 | clinicaltrials |
| NCT00095108 | Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer | completed | Phase 1 | 43 | ZymoGeneticsINDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00827203 | A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors | suspended | Phase 1 | 30 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00006347 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00006458 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00122005 | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | unknown | Phase 1 / Phase 2 | 18 | Providence Health & ServicesOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00374179 | CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma | completed | Phase 1 | 40 | Adnexus, A Bristol-Myers Squibb R&D CompanyINDUSTRY | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00003409 | Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00003977 | Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer | completed | Phase 1 | — | Steward St. Elizabeth's Medical Center of Boston, Inc.OTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00004028 | Carmustine in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00004892 | O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00032097 | Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00033410 | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | California Cancer ConsortiumNETWORK | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00045474 | Brachytherapy in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00053183 | Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | completed | Phase 1 | 240 | Stony Brook UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00304200 | Temodar and Sutent as Therapy for Melanoma | terminated | Phase 1 / Phase 2 | 7 | Northern California Melanoma CenterOTHER | 1 | Feb 5, 2009 | clinicaltrials |
| NCT00499499 | A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors | suspended | Phase 1 | 40 | Eisai Inc.INDUSTRY | 1 | Feb 4, 2009 | clinicaltrials |
| NCT00086099 | Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 54 | MedImmune LLCINDUSTRY | 2 | Jan 29, 2009 | clinicaltrials |
| NCT00621556 | Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas | terminated | Phase 1 | 2 | Massachusetts General HospitalOTHER | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00174434 | Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer | completed | Phase 1 | 22 | PfizerINDUSTRY | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00611793 | PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies | completed | Phase 1 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00364572 | Efficacy of Epidural Etanercept in the Treatment of Sciatica | completed | Phase 1 / Phase 2 | 24 | Johns Hopkins UniversityOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00435669 | A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664) | completed | Phase 1 | 4 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00017264 | Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00075894 | Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00821301 | Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma | unknown | Phase 1 | 30 | Immune ControlINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00709215 | Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia | unknown | Phase 1 / Phase 2 | 44 | OncoVista, Inc.INDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials